Neutraceuticals
Description:
Based on a recent international conference, this breakthrough resource examines the present status of research on nutraceuticals;foods or food parts that offer medical;health benefits, including the prevention or treatment of disease. Addresses how current regulations make it economically feasible to conduct preclinical and clinical studies to substantiate medical claims for nutraceuticals! Discussing medical, functional, and designer foods; dietary supplements; and other food categories, Nutraceuticals furnishes concise background information on the history of nutraceuticals demonstrates the requirements for making claims regarding health benefits elucidates European perspectives on medical foods delineates the position of the U.S. Food and Drug Administration on nutraceuticals explains the Dietary Supplements, Health and Education Act and the Nutrition Labeling and Education Act presents case histories of nutraceuticals in the medical treatment of hypertension, diabetes, and benign prostatic hyperplasia and more! Written by leading experts in medicine, pharmacology, law, and business, Nutraceuticals is a useful reference for food scientists; composition and nutrition engineers; biochemists; nutritionists; pharmacologists; internists; cardiologists; gerontologists; dietitians; research and development personnel, marketers, and executives in the food industry; and graduate students in these disciplines.
Best prices to buy, sell, or rent ISBN 9780824701079
Frequently Asked Questions about Neutraceuticals
The price for the book starts from $83.99 on Amazon and is available from 3 sellers at the moment.
If you’re interested in selling back the Neutraceuticals book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Neutraceuticals book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.